Correlation of <i>CCR4</i> aberrations with clinical features and immunophenotypes of neoplastic cells in patients with adult T-cell leukemia/lymphoma treated at our institution-Reference-Cited by-同舟云学术

Correlation of CCR4 aberrations with clinical features and immunophenotypes of neoplastic cells in patients with adult T-cell leukemia/lymphoma treated at our institution

Published:2021-12-25 Issue:2 Volume:24 Page:76-90
ISSN:1344-1817
Container-title:Tenri Medical Bulletin
language:en
Short-container-title:Tenri Med Bull

Author:

Chagi Yoshinari¹,Hayashida Masahiko¹,Kataoka Naoki²,Maekawa Fumiyo¹,Takeoka Kayo¹,Masutani Hiroshi²,Ohno Hitoshi¹

Affiliation:

1. Tenri Institute of Medical Research

2. Department of Clinical Laboratory Science, Faculty of Health Care, Tenri Health Care University

Publisher

Tenri Foundation, Tenri Institute of Medical Research

Link

https://www.jstage.jst.go.jp/article/tenrikiyo/24/2/24_76/_pdf

Reference22 articles.

1. 1. Oshima K, Jaffe ES, Yoshino T, et al. Adult T-cell leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). Lyon: IARC; 2017:363-367

2. 2. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007;25:5458-5464

3. 3. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010;116:1369-1376

4. 4. Ishida T, Utsunomiya A, Iida S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003;9:3625-3634

5. 5. Ogura M, Ishida T, Hatake K, et al. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J Clin Oncol 2014;32:1157-1163